- Home
- INBX vs PCT Comparison
INBX vs PCT Comparison
Compare INBX & PCT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | INBX | PCT |
|---|---|---|
| Founded | 2010 | 2015 |
| Country | United States | United States |
| Employees | N/A | 174 |
| Industry | Biotechnology: Pharmaceutical Preparations | Environmental Services |
| Sector | Health Care | Utilities |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 999.7M | 955.4M |
| IPO Year | 2024 | N/A |
Fundamental Metrics
Financial Performance| Metric | INBX | PCT |
|---|---|---|
| Price | $117.53 | $12.30 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 3 | 3 |
| Target Price | ★ $150.00 | $13.00 |
| AVG Volume (30 Days) | 582.2K | ★ 3.7M |
| Earning Date | 05-15-2026 | 05-06-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $1,300,000.00 | N/A |
| Revenue This Year | N/A | $380.44 |
| Revenue Next Year | N/A | $203.33 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ 550.00 | N/A |
| 52 Week Low | $12.80 | $4.93 |
| 52 Week High | $155.29 | $17.37 |
Technical Indicators
Market Signals| Indicator | INBX | PCT |
|---|---|---|
| Relative Strength Index (RSI) | 53.89 | 86.50 |
| Support Level | $69.30 | $7.87 |
| Resistance Level | $155.29 | $12.31 |
| Average True Range (ATR) | 12.57 | 0.69 |
| MACD | -2.94 | 0.40 |
| Stochastic Oscillator | 34.41 | 88.83 |
Price Performance
Historical ComparisonAbout INBX Inhibrx Inc.
Inhibrx Biosciences Inc is a clinical-stage biopharmaceutical company with a pipeline of novel biologic therapeutic candidates, developed using its proprietary modular protein engineering platforms. Its clinical pipeline of therapeutic candidates includes INBRX-109 and INBRX-106, both of which utilize their multivalent formats where the precise valency can be optimized in a target-centric way to mediate what experts consider to be the predominant agonist function.
About PCT PureCycle Technologies Inc.
PureCycle Technologies Inc is a Florida-based corporation focused on commercializing a patented dissolution process to physically separate the polymer from other plastics, color, and contaminants (the Technology), originally developed by The Procter & Gamble Company (P&G), for restoring waste polypropylene into resin with near-virgin characteristics, called PureFive resin. PureFive resin represents the family of recycled resin products produced, including ultra-pure resin and other grades used for compounding to meet customer specifications, which has similar properties and applicability for reuse as virgin polypropylene. It has a single operating segment, which encompasses integrated business activities related to the recycling of polypropylene into resins.